
Sign up to save your podcasts
Or


In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:
By Bernard Marini, Anthony Perissinotti, et al.4.5
2828 ratings
In the first of a two part-series, Anthony and Bernie dive into the data surrounding maintenance therapies in AML. This episode focuses on maintenance therapy for patients ineligible for transplant, with a focus on oral azacitidine and the controversial QUAZAR study.
Key References:

498 Listeners

28 Listeners

184 Listeners

8,187 Listeners

2 Listeners

756 Listeners

12 Listeners

53 Listeners

57 Listeners

136 Listeners

1 Listeners

49 Listeners

185 Listeners

43 Listeners

3 Listeners